Comprehensive clinical review of liraglutide for T2DM: once-daily injection, superior HbA1c reduction, weight loss, cardiovascular safety signals, and positioning in treatment algorithms.
Key findingComprehensive clinical review of liraglutide for T2DM: once-daily injection, superior HbA1c reduction, weight loss, cardiovascular safety signals, and
What the researchers found
Comprehensive clinical review of liraglutide for T2DM: once-daily injection, superior HbA1c reduction, weight loss, cardiovascular safety signals, and positioning in treatment algorithms.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2011.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Liraglutide: a review of its use in the management of type 2 diabetes mellitus.
Drugs, 71(17), 2347-73
Citation
Perry, Caroline M. (2011). Liraglutide: a review of its use in the management of type 2 diabetes mellitus.. Drugs, 71(17), 2347-73. https://doi.org/10.2165/11208110-000000000-00000